This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Towers, A. L. Articles by Greenspan, S. L. Search for Related Content PubMed PubMed Citation Articles by Towers, A. L. Articles by Greenspan, S. L. Pubmed/NCBI databases OMIM Medline Plus Health Information Joint Disorders Related Collections Calcium and Bone Metabolism

Skeletal Integrity in Patients with Nail Patella Syndrome

Division of Geriatric Medicine (A.L.T., S.L.G.), Osteoporosis Prevention and Treatment Center (C.A.C., S.L.G.), Department of Medicine, Departments of Health and Community Systems, Biostatistics, and Epidemiology, School of Nursing and Graduate School of Public Health (S.M.S.), University of Pittsburgh, Pittsburgh, Pennsylvania 15213-3221; and McKusick-Nathans Institute of Genetic Medicine (I.M.), Johns Hopkins University, Baltimore, Maryland 21205

Address all correspondence and requests for reprints to: Susan L. Greenspan, M.D., University of Pittsburgh, Osteoporosis Prevention and Treatment Center, Kaufmann Medical Building, Suite 1110, 3471 Fifth Avenue, Pittsburgh, Pennsylvania 15213-3221. E-mail griffithsd{at}msx.dept-med.pitt.edu.

Nail patella syndrome (NPS) is a rare autosomal dominant disorder resulting from a heterogenous loss of function in the LMX1B gene. It is associated with multiple skeletal deformities, yet it is unknown whether this is associated with osteoporosis. To examine bone mass and the prevalence of fragility fractures, we assessed bone mineral density (BMD) of the spine and hip in 31 adults and 12 children with mutation-confirmed NPS and 60 healthy age- and gender-matched adult controls. For the adults with NPS, BMD was 11–20% lower at the hip sites (P 0.001) and 8% lower at the spine (P < 0.05) than that of controls. Even when adjusted for body mass index, the BMD remained significantly lower in patients with NPS in all hip regions but not in the spine. Adults with NPS also had a significantly lower Z-score (SD values from normal) at all hip sites (all P < 0.05), compared with age- and gender-matched controls in the manufacturer’s database. However, children had significantly lower Z-scores only at the femoral neck and trochanter. Participants with NPS also had a higher prevalence of fractures (odds ratio 30.9, 95% confidence interval 6.4–149.6, P < 0.001) and scoliosis (odds ratio 16.0, 95% confidence interval 3.3–78.2, P < 0.001). The majority of these fractures occurred in women before puberty and in long bones, especially the clavicle. We conclude that adults with NPS have a BMD that is 8–20% lower than controls, which is associated with an increase in the prevalence of fractures and scoliosis. Future studies are needed to determine whether bone quality, geometry, or turnover could account for these findings.

This article has been cited by other articles:

				S. L. Greenspan, A. Brufsky, B. C. Lembersky, R. Bhattacharya, K. T. Vujevich, S. Perera, S. M. Sereika, and V. G. Vogel Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial J. Clin. Oncol., June 1, 2008; 26(16): 2644 - 2652. [Abstract] [Full Text] [PDF]

				S. L. Greenspan, R. K. Bhattacharya, S. M. Sereika, A. Brufsky, and V. G. Vogel Prevention of Bone Loss in Survivors of Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 131 - 136. [Abstract] [Full Text] [PDF]